Advertisement
Loading...

Trevena, Inc.

TRVNNASDAQ
Healthcare
Biotechnology
$0.001
$-0.01(-90.99%)
U.S. Market is Open • 13:55
Advertisement

Trevena, Inc. Fundamental Analysis

Trevena, Inc. (TRVN) shows weak financial fundamentals with a PE ratio of -0.00, profit margin of -12.89%, and ROE of -10.15%. The company generates $0.0B in annual revenue with N/A year-over-year growth of N/A.

Key Strengths

Cash Position232359.65%
PEG Ratio-0.00
Current Ratio4.66

Areas of Concern

ROE-10.15%
Operating Margin-11.29%
We analyze TRVN's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of -2384.6/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.

Fundamental Health Score

F
-2384.6/100

We analyze TRVN's fundamental strength across five key dimensions:

Efficiency Score

Weak

TRVN struggles to generate sufficient returns from assets.

ROA > 10%
-99.22%

Valuation Score

Excellent

TRVN trades at attractive valuation levels.

PE < 25
-0.00
PEG Ratio < 2
-0.00

Growth Score

Weak

TRVN faces weak or negative growth trends.

Revenue Growth > 5%
N/A
EPS Growth > 10%
N/A

Financial Health Score

Excellent

TRVN maintains a strong and stable balance sheet.

Debt/Equity < 1
-4.73
Current Ratio > 1
4.66

Profitability Score

Weak

TRVN struggles to sustain strong margins.

ROE > 15%
-1014.58%
Net Margin ≥ 15%
-12.89%
Positive Free Cash Flow
No

Key Financial Metrics

Is TRVN Expensive or Cheap?

P/E Ratio

TRVN trades at -0.00 times earnings. This suggests potential undervaluation.

-0.00

PEG Ratio

When adjusting for growth, TRVN's PEG of -0.00 indicates potential undervaluation.

-0.00

Price to Book

The market values Trevena, Inc. at -0.00 times its book value. This may indicate undervaluation.

-0.00

EV/EBITDA

Enterprise value stands at 0.09 times EBITDA. This is generally considered low.

0.09

How Well Does TRVN Make Money?

Net Profit Margin

For every $100 in sales, Trevena, Inc. keeps $-12.89 as profit after all expenses.

-12.89%

Operating Margin

Core operations generate -11.29 in profit for every $100 in revenue, before interest and taxes.

-11.29%

ROE

Management delivers $-10.15 in profit for every $100 of shareholder equity.

-10.15%

ROA

Trevena, Inc. generates $-99.22 in profit for every $100 in assets, demonstrating efficient asset deployment.

-99.22%

Following the Money - Real Cash Generation

Operating Cash Flow

Trevena, Inc. generates limited operating cash flow of $-2.01M, signaling weaker underlying cash strength.

$-2.01M

Free Cash Flow

Trevena, Inc. generates weak or negative free cash flow of $-2.01M, restricting financial flexibility.

$-2.01M

FCF Per Share

Each share generates $-2.33 in free cash annually.

$-2.33

FCF Yield

TRVN converts -38282.41% of its market value into free cash.

-38282.41%

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

-0.00

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

-0.00

vs 25 benchmark

P/B Ratio

Price to book value ratio

-0.00

vs 25 benchmark

P/S Ratio

Price to sales ratio

0.00

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

-4.73

vs 25 benchmark

Current Ratio

Current assets to current liabilities

4.66

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

-10.15

vs 25 benchmark

ROA

Return on assets percentage

-0.99

vs 25 benchmark

ROCE

Return on capital employed

-1.07

vs 25 benchmark

How TRVN Stacks Against Its Sector Peers

MetricTRVN ValueSector AveragePerformance
P/E Ratio-0.0029.35 Better (Cheaper)
ROE-1014.58%705.00% Weak
Net Margin-1289.25%-53441.00% (disorted) Weak
Debt/Equity-4.730.39 Strong (Low Leverage)
Current Ratio4.664.01 Strong Liquidity
ROA-99.22%-19815.00% (disorted) Weak

TRVN outperforms its industry in 3 out of 6 key metrics, but lagging in ROE.

Historical Growth Performance

5-Year Growth Trajectory

This section reviews Trevena, Inc.'s 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

N/A

Industry Style: Defensive, Growth, Innovation

EPS CAGR

N/A

Industry Style: Defensive, Growth, Innovation

FCF CAGR

N/A

Industry Style: Defensive, Growth, Innovation

Fundamental Analysis FAQ